Literature DB >> 1632464

Flow cytometric analysis of pulmonary fluids and cells for the detection of malignancies.

J E Fuhr1, A A Kattine, T A Sullivan, H S Nelson.   

Abstract

Cells from a pulmonary or bronchial origin were analyzed with flow cytometry to assess the sensitivity and specificity of this method in diagnosing malignancy. In all instances, cells submitted for flow cytometry analysis were excess cells from specimens submitted for routine cytology. Less than 3% of all samples were rejected for insufficient material. Overall sensitivity from all sources was 86%, specificity 96%. Although cytology results were the standard for determining accuracy of flow cytometry, in a few patients cytology appeared normal and initial evidence for malignancy was obtained from flow cytometry. For this reason, flow cytometry may be a valuable adjunctive technology in the diagnosis of malignancy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1632464      PMCID: PMC1886592     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  15 in total

1.  Transthoracic aspiration needle biopsy: value in the diagnosis of pulmonary infections.

Authors:  D J Conces; S A Clark; R D Tarver; G R Schwenk
Journal:  AJR Am J Roentgenol       Date:  1989-01       Impact factor: 3.959

2.  Flow cytometric analysis of breast needle aspirates.

Authors:  J O Palmer; R W McDivitt; K R Stone; M A Rudloff; J G Gonzalez
Journal:  Cancer       Date:  1988-12-01       Impact factor: 6.860

3.  DNA flow cytometry applied to fine needle sampling of human breast cancer.

Authors:  Y Remvikos; H Magdelénat; A Zajdela
Journal:  Cancer       Date:  1988-04-15       Impact factor: 6.860

Review 4.  Flow cytometry in clinical cancer research.

Authors:  B Barlogie; M N Raber; J Schumann; T S Johnson; B Drewinko; D E Swartzendruber; W Göhde; M Andreeff; E J Freireich
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

5.  Measurement of cellular DNA content as an adjunct to diagnostic cytology in malignant effusions.

Authors:  D W Hedley; J Philips; C A Rugg; I W Taylor
Journal:  Eur J Cancer Clin Oncol       Date:  1984-06

6.  Analysis of pleural effusions using automated flow cytometry.

Authors:  K M Unger; M Raber; C W Bedrossian; D A Stein; B Barlogie
Journal:  Cancer       Date:  1983-09-01       Impact factor: 6.860

7.  Flow cytometry of normal and nonneoplastic diseases of the bladder: an estimate of the false positive rate.

Authors:  F A Klein; H W Herr; P C Sogani; W F Whitmore; M R Melamed
Journal:  J Urol       Date:  1982-05       Impact factor: 7.450

8.  DNA flow cytometry of pleural effusions. Comparison with pathology for the diagnosis of malignancy.

Authors:  D A Evans; J T Thornthwaite; A B Ng; E V Sugarbaker
Journal:  Anal Quant Cytol       Date:  1983-03

9.  Flow cytometric analysis and cytopathology of body cavity fluids.

Authors:  K J Stonesifer; J H Xiang; E J Wilkinson; N A Benson; R C Braylan
Journal:  Acta Cytol       Date:  1987 Mar-Apr       Impact factor: 2.319

10.  Prospective evaluation of fine needle aspiration in the diagnosis of lung cancer.

Authors:  D Veale; J J Gilmartin; M D Sumerling; V Wadehra; G J Gibson
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.